申请人:——
公开号:US20030134830A1
公开(公告)日:2003-07-17
A compound is provided for increasing the concentration of a parent androgen in a subject in vivo. The parent androgen has a skeletal structure including a 1 position and a 17 position, a 17&bgr;-hydroxy group comprising a 17&bgr;-hydroxy oxygen appended to the 17 position, and a 17&bgr;-hydroxy hydrogen appended to the 17&bgr;-hydroxy oxygen. The compound includes a substrate having the skeletal structure of the parent androgen. It includes a 1 position and a 17 position corresponding to the 1 and 17 positions respectively of the parent androgen. The substrate has a carbon-carbon double bond at the 1 position. The compound also has a promoiety appended to the 17&bgr;-hydroxy oxygen of the substrate as a substitute for the 17&bgr;-hydroxy hydrogen of the parent androgen. The promoiety includes, and preferably consists of, an alkylcarbonate ester. A related method also is provided.
本发明提供了一种化合物,用于提高体内受试者体内母体雄激素的浓度。母体雄激素的骨架结构包括1位和17位,17&bgr;-羟基包括与17位相连的17&bgr;-羟基氧和与17&bgr;-羟基氧相连的17&bgr;-羟基氢。该化合物包括具有母体雄激素骨架结构的底物。它包括一个 1 位和一个 17 位,分别对应于母体雄激素的 1 位和 17 位。底物在 1 位上有一个碳碳双键。该化合物还有一个原基附加在底物的 17&bgr;-羟基氧上,以替代母体雄激素的 17&bgr;-羟基氢。原基包括,最好是烷基碳酸酯。还提供了一种相关的方法。